Latest & Upcoming Technology Updates
New Delhi: Observing that “all is not well” in the city’s health department which is witnessing a “bitter” fight between authorities, the Delhi High Court on Monday tasked the AIIMS…
Bengaluru: Neurocrine Biosciences said on Wednesday its drug helped reduce the severity of schizophrenia symptoms in a mid-stage trial, but its shares fell nearly 17 per cent on worries whether…
Bengaluru: Biocon Biologics Ltd (BBL), a biosimilars company and a subsidiary of Biocon Ltd, announced that it has signed a settlement and license agreement with Janssen Biotech Inc., Janssen Sciences…
New Delhi: Union Minister of State for Commerce & Industry Jitin Prasada highlighted India’s emergence as a premier, cost-effective healthcare destination and a global leader in pharmaceuticals. According to the…
London: Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday, marking the latest set of trial…
New Delhi: Natco Pharma on Thursday said it has submitted a product application with the US health regulator for a generic product indicated for the treatment of metastatic non-small cell…
Mumbai: Lupin Limited announced the launch of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials in the US after Lupin’s alliance…
London: The U.S. Food and Drug Administration (FDA) has approved expanded use of Emergent BioSolutions‘ ACAM2000 smallpox vaccine to include people at high risk for mpox infection, the company said…
Bengaluru: Contract drug manufacturer Catalent beat analysts’ estimates for fourth-quarter revenue on Thursday, helped by its biologics segment that develops and manufactures cell and gene therapies. WHY IT’S IMPORTANT The…
New Delhi: Zydus Lifesciences Ltd on Friday said the US health regulator has issued a warning letter for its injectables manufacturing facility at Jarod near Vadodara, Gujarat over violations of…